Key PointsPfizer shares have underperformed since 2021, with the recent poor performance reflecting concerns about impending patent expirations.
POLARIS INSIGHTS
POLARIS INSIGHTS
Key PointsPfizer shares have underperformed since 2021, with the recent poor performance reflecting concerns about impending patent expirations.